You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Tegafur

Showing 1 - 25 of 201
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Head and Neck Squamous Cell Carcinoma Trial in Shanghai (Apatinib Mesylate Tablets, Tegafur Gimeracil Oteracil Potassium

Completed
  • Head and Neck Squamous Cell Carcinoma
  • Apatinib Mesylate Tablets
  • Tegafur Gimeracil Oteracil Potassium Capsules
  • Shanghai, Shanghai, China
    Shanghai ninth people's hospital
Jul 20, 2022

Liver Metastases Trial in Hangzhou (Tislelizumab in Combination with Oxaliplatin and Tegafur)

Recruiting
  • Liver Metastases
  • Tislelizumab in Combination with Oxaliplatin and Tegafur
  • Hangzhou, Zhejiang, China
    gastrointestinal department of second affiliated hospital of Zhe
Jan 31, 2023

Gastric Cancer Trial (Sintilimab)

Not yet recruiting
  • Gastric Cancer
  • (no location specified)
Oct 21, 2022

Gastric Cancer Trial (Envolimab, Fuquinitinib, Oxaliplatin)

Not yet recruiting
  • Gastric Cancer
  • (no location specified)
Jun 13, 2023

Resectable Gastric or Gastroesophageal Junction Adenocarcinoma Trial (Cadonilimab, AK117, Oxaliplatin)

Not yet recruiting
  • Resectable Gastric or Gastroesophageal Junction Adenocarcinoma
  • (no location specified)
Jul 17, 2023

Esophageal Trial in Nanjing ("Endostar", Liposo, cisplatin)

Terminated
  • Esophageal
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Jul 28, 2022

Gastric Cancer Stage III Trial in China (Camrelizumab, Oxaliplatin, Tegafur gimeracil oteracil potassium capsule)

Recruiting
  • Gastric Cancer Stage III
  • Hangzhou, Zhejiang, China
  • +3 more
Feb 4, 2022

Gastric Cancer Trial in Beijing (Apatinib, Oxaliplatin, S1)

Recruiting
  • Gastric Cancer
  • Beijing, Beijing, China
    Beijing Cancer Hospital / Peking University Cancer Hospital
Jan 30, 2023

Locally Advanced Gastric Adenocarcinoma, Chemo Effect Trial in Hanzhou (Docetaxel, Tegafur-Gimeracil-Oteracil)

Recruiting
  • Locally Advanced Gastric Adenocarcinoma
  • Chemotherapy Effect
  • Hanzhou, Zhejiang, China
    Gastrointestinal Department of Second Affiliated Hospital of Zhe
Apr 2, 2023

Esophageal Cancer, Radiation Therapy, Immunotherapy Trial in Taizhou (Toripalimab, Tegafur, IMRT)

Recruiting
  • Esophageal Cancer
  • +3 more
  • Taizhou, Zhejiang, China
  • +1 more
Apr 15, 2023

Stomach Cancer Trial in Seoul (S-1 (452500ACH), OXALIPLATIN (205803BIJ))

Terminated
  • Stomach Cancer
  • S-1 (452500ACH)
  • OXALIPLATIN (205803BIJ)
  • Seoul, Korea, Republic of
    Kangbuk Samsung Hospital
Dec 6, 2022

Pancreatic Ductal Adenocarcinoma, Advanced Solid Tumor Trial in Petaling Jaya (Dendritic cell + Cytokine-induced killer cell

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Advanced Solid Tumor
  • Dendritic cell + Cytokine-induced killer cell (DC+CIK) immunotherapy
  • Tegafur Only Product
  • Petaling Jaya, Kuala Lumpur, Malaysia
    Clinical Oncology Department, Ummc
Jul 12, 2023

Gastric Cancer Trial (Disitamab Vedotin, Sintilimab, S-1)

Not yet recruiting
  • Gastric Cancer
  • Disitamab Vedotin
  • +3 more
  • (no location specified)
Nov 17, 2022

Immunotherapy, Gastrict Cancer Trial in Fuzhou (Tislelizumab, Apatinib Mesylate, oxaliplatin)

Recruiting
  • Immunotherapy
  • Gastrict Cancer
  • Fuzhou, China
    Fujian cancer hospital
Jan 17, 2023

For Patients With Colorectal Cancer Liver Metastases Who Were Not Able to Curative Surgical Resection.Focused on the Treatment

Not yet recruiting
  • For Patients With Colorectal Cancer Liver Metastases Who Were Not Able to Curative Surgical Resection.Focused on the Treatment Effect With the Quintuple Method
  • Shenyang, Liaoning, China
    Liaoning Tumor Hospital & Institute
Mar 7, 2023

HER2-positive Gastric Cancer Trial in Shenyang (Camrelizumab +Pyrotinib + Nab-paclitaxel + Tegafur)

Recruiting
  • HER2-positive Gastric Cancer
  • Camrelizumab +Pyrotinib + Nab-paclitaxel + Tegafur
  • Shenyang, China
    Shengjing Hospital of China Medical University
Sep 27, 2021

Adjuvant Huaier Granule Versus SOX in Gastric Cancer Patients

Not yet recruiting
  • Gastric Cancer
  • Huaier granule
  • +2 more
  • Wuhan, Hubei, China
    Wuhan Union Hospital
Aug 11, 2022

Capecitabine Versus S-1 as Adjuvant Therapy in Biliary Tract

Recruiting
  • Biliary Tract Neoplasms
  • +3 more
  • Shanghai, China
    Huashan hospital
Aug 16, 2022

Advanced Biliary Tract Carcinoma Trial in Hangzhou (Camrelizumab, apatinib, gemcitabine, oxaliplatin, tegafur)

Not yet recruiting
  • Advanced Biliary Tract Carcinoma
  • Camrelizumab, apatinib, gemcitabine, oxaliplatin, tegafur
  • Hangzhou, Zhejiang, China
    the First Affiliated Hospital, School of Medicine, Zhejiang Univ
Jul 6, 2022

Metastatic Solid Tumor, NSCLC, Gastric Cancer Trial (RO7496353, Atezolizumab, Capecitabine)

Not yet recruiting
  • Metastatic Solid Tumor
  • +3 more
  • (no location specified)
May 22, 2023

Chemotherapy(Docetaxel, Oxaliplatin Plus S1 ) Followed With

Enrolling by invitation
  • Gastric Cancer
  • Gastrectomy
  • +3 more
  • Shanghai, Shanghai, China
    Zhongshan hospital
May 1, 2022

Stomach Tumors, Peritoneal Metastases Trial (HIPEC, Paclitaxel-albumin, Tegafur-gimeracil-oteracil potassium)

Not yet recruiting
  • Stomach Neoplasms
  • Peritoneal Metastases
  • HIPEC
  • +3 more
  • (no location specified)
Oct 26, 2021

Gastric Cancer in Situ, Pancreatic Cancers, Biliary Cancers Trial in Taipei (Oxaliplatin, Albumin-Bound Paclitaxel

Completed
  • Gastric Cancer in Situ
  • +2 more
  • Taipei, Taiwan
    Taiwan Cooperative Oncology Group, National Health Research Inst
Apr 5, 2022

Stomach Tumors, Esophagogastric Junction Disorder, Neoadjuvant Therapy Trial in Shanghai (drug, radiation, procedure)

Recruiting
  • Stomach Neoplasms
  • +7 more
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Dec 3, 2021

Nasopharyngeal Carcinoma Trial in Hangzhou (Tegafur-Gimeracil-Oteracil)

Recruiting
  • Nasopharyngeal Carcinoma
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital
Jun 21, 2021